These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 9988012)

  • 1. Use of approximate entropy measurements to classify ventricular tachycardia and fibrillation.
    Schuckers SA
    J Electrocardiol; 1998; 31 Suppl():101-5. PubMed ID: 9988012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular Tachyarrhythmias in Patients With Hypertrophic Cardiomyopathy and Defibrillators: Triggers, Treatment, and Implications.
    Link MS; Bockstall K; Weinstock J; Alsheikh-Ali AA; Semsarian C; Estes NAM; Spirito P; Haas TS; Rowin EJ; Maron MS; Maron BJ
    J Cardiovasc Electrophysiol; 2017 May; 28(5):531-537. PubMed ID: 28240435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive scheme for detection of ventricular fibrillation for implantable cardioverter defibrillators.
    Caswell SA; Jenkins JM; DiCarlo LA
    J Electrocardiol; 1998; 30 Suppl():131-6. PubMed ID: 9535490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.
    Baquero GA; Banchs JE; Depalma S; Young SK; Penny-Peterson ED; Samii SM; Wolbrette DL; Naccarelli GV; Gonzalez MD
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):296-301. PubMed ID: 21955243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High amplitude T-wave alternans precedes spontaneous ventricular tachycardia or fibrillation in ICD electrograms.
    Swerdlow CD; Zhou X; Voroshilovsky O; Abeyratne A; Gillberg J
    Heart Rhythm; 2008 May; 5(5):670-6. PubMed ID: 18452868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Device Therapies for Ventricular Arrhythmias or Death in the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) Trial.
    Tompkins CM; Kutyifa V; Arshad A; McNitt S; Polonsky B; Wang PJ; Moss AJ; Zareba W
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):862-871. PubMed ID: 25929699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG; Stanton MS; Benditt DG; Trusty J; Collins J
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence rather than costs must guide use of the implantable cardioverter defibrillator.
    Delacretaz E; Schlaepfer J; Metzger J; Fromer M; Kappenberger L
    Am J Cardiol; 2000 Nov; 86(9A):52K-57K. PubMed ID: 11084101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.
    Li CH; Lin YJ; Huang JL; Wu TJ; Cheng CC; Lin WS; Tuan TC; Chang SL; Lo LW; Hu YF; Chao TF; Chung FP; Tsai CF; Tsao HM; Chen SA
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):750-6. PubMed ID: 22353378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of the Wearable Cardioverter-Defibrillator in Protecting Patients After Implantable-Cardioverter Defibrillator Explant: Results From the National Registry.
    Ellenbogen KA; Koneru JN; Sharma PS; Deshpande S; Wan C; Szymkiewicz SJ
    JACC Clin Electrophysiol; 2017 Mar; 3(3):243-250. PubMed ID: 29759518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).
    Guerra F; Palmisano P; Dell'Era G; Ziacchi M; Ammendola E; Bonelli P; Patani F; Cupido C; Devecchi C; Accogli M; Occhetta E; Santangelo L; Biffi M; Boriani G; Capucci A;
    Heart Rhythm; 2016 Oct; 13(10):1987-92. PubMed ID: 27291511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular tachycardia during follow-up in patients resuscitated from ventricular fibrillation: experience from stored electrograms of implantable cardioverter-defibrillators.
    Rüppel R; Schlüter CA; Boczor S; Meinertz T; Schlüter M; Kuck KH; Cappato R
    J Am Coll Cardiol; 1998 Nov; 32(6):1724-30. PubMed ID: 9822102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Detection of ventricular tachycardia and ventricular fibrillation based on joint entropy].
    Chen J; Wang J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):24-7. PubMed ID: 20337018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular arrhythmia detection for contemporary Biotronik and Abbott implantable cardioverter defibrillators with markedly prolonged detection in Biotronik devices.
    Oesterle A; Dhruva SS; Pellegrini CN; Liem B; Raitt MH
    J Interv Card Electrophysiol; 2023 Oct; 66(7):1679-1691. PubMed ID: 36737506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm.
    Grimm W; Menz V; Hoffmann J; Maisch B
    Pacing Clin Electrophysiol; 1998 Apr; 21(4 Pt 1):722-7. PubMed ID: 9584303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of functional changes in ventricular late potentials for risk assessment of ventricular tachycardias after myocardial infarct].
    Steinbigler P; Haberl R; Jilge G; Knez A; Dorwarth U; Müller D; Hoffmann E; Steinbeck G
    Z Kardiol; 1998 Jun; 87(6):459-70. PubMed ID: 9691416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential hazards of fixed gain sensing and arrhythmia reconfirmation for implantable cardioverter defibrillators.
    Singer I; Adams L; Austin E
    Pacing Clin Electrophysiol; 1993 May; 16(5 Pt 1):1070-9. PubMed ID: 7685888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.